BiondVax Pharmaceuticals Ltd.

Historical 13F Holders

Symbol
BVXV
CUSIP
09073Q105
All holders as of
Q3 2022
Type
Equity
Class
SPOND ADS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q3 13 210 k $153 k
2022 Q2 16 334 k $389 k
2022 Q1 20 330 k $544 k
2021 Q4 16 336 k $789 k
2021 Q3 19 255 k $560 k
2021 Q2 18 311 k $891 k
2021 Q1 21 284 k $1.08 M
2020 Q4 15 222 k $623 k
2020 Q3 19 539 k $21.1 M
2020 Q2 16 506 k $11.5 M
2020 Q1 10 405 k $3.12 M
2019 Q4 12 477 k $4.43 M
2019 Q3 9 406 k $2.41 M
2019 Q2 8 406 k $2.34 M
2019 Q1 12 427 k $2.27 M
2018 Q4 11 446 k $2.13 M
2018 Q3 13 451 k $2.53 M
2018 Q2 13 454 k $3.03 M
2018 Q1 16 487 k $2.64 M
2017 Q4 12 497 k $2.61 M
2017 Q3 8 106 k $689 k
2017 Q2 6 28.5 k $164 k
2017 Q1 7 72.8 k $367 k
2016 Q4 3 39.0 k $102 k
2016 Q3 4 32.6 k $119 k
2016 Q2 3 33.4 k $118 k
2016 Q1 4 32.8 k $122 k
2015 Q4 3 32.0 k $126 k
2015 Q3 6 48.2 k $177 k
2015 Q2 6 100 k $495 k